In 2026, the average practice is writing off claims it already won. A $47 office visit gets denied on a CARC 197 prior-auth technicality, sits in a work queue for 43 days, and then gets adjusted off because your biller calculated — correctly — that reworking it costs more than the claim is worth. Meanwhile UnitedHealthcare’s automated adjudication is denying at a rate your 2019 playbook never anticipated, Medicare Advantage plans are inventing new documentation requirements quarterly, and your 835 remittance files are landing in a folder nobody opens. The money isn’t lost. It’s just unclaimed, sitting in the gap between what a human can profitably appeal and what an AI can appeal for pennies.
This is for practice owners, RCM managers, billing company operators, and consultants who want to build a denial recovery function — or sell one. You should already know what a claim is, roughly how your clearinghouse works, and who your top three payers are. You do not need to code. You do not need to have used AI beyond typing into a chat box. Out of scope: front-desk workflow redesign, coding education (this assumes your CPT/ICD-10 is competent), contract negotiation with payers, and anything involving building your own machine learning models. This is about deploying tools that exist and getting paid this quarter.
Honest framing: AI is exceptional at pattern recognition across your remittance history — it will spot that a specific payer denies a specific code combination 71% of the time, faster and more reliably than any human reviewer. It drafts appeal letters that cite the right CARC context and payer policy language at a speed no biller can match. It is bad at clinical judgment, it will confidently hallucinate a policy citation if you let it, and it has no idea whether your documentation actually supports the level of service you billed. Every appeal goes out under a human signature after human review — that is not a compliance suggestion, it is the line between a recovered claim and a false claims exposure. PHI handling has hard rules and this guide does not soften them.
What This Guide Covers
- Why denial recovery became the highest-margin arbitrage in healthcare in 2026 — and the specific window that’s closing
- How to read the 837/835 loop the way payers do, so you can see exactly where and why your claims die
- A candid comparison of Adonis, Infinx, AKASA, Waystar AltitudeAI, and Candid Health — what each is actually good at, and what you’d be overpaying for
- How to stand up predictive denial scoring so problem claims get caught before submission, not 45 days after
- Automating prior authorization — the single largest source of preventable denials — without adding headcount
- Building an appeal-drafting workflow that produces letters payers overturn, mapped to the CARC/RARC codes driving your specific denials
- An automation pipeline that parses incoming remittance files and outputs a recovery queue ranked by dollars-per-minute-of-effort
- Payer-specific weak points — where UnitedHealthcare, Aetna, and Medicare Advantage each fold, and where they won’t
- Connecting to Athenahealth, eClinicalWorks, or DrChrono without breaking your existing billing workflow
- The HIPAA and BAA realities of putting claims data near an AI model — what requires a signed agreement, what requires de-identification, and what you simply cannot do
- Real cost-per-claim math comparing AI-assisted rework to human rework, so you know your true break-even on low-dollar claims
- How to package this as a contingency-fee recovery service at 8–15% — pricing, scope, and the objections you’ll hear
- A 30-day proof structure designed to convert a skeptical practice manager using recovered dollars rather than promises
- What’s coming: No Surprises Act enforcement, CMS interoperability mandates, and the 2027 risks that could compress this margin
Instant access the moment checkout completes — the full guide is available online immediately, no waiting, no shipping. One purchase, one price. There is no upsell, no course pitch, and no locked bonus chapter.
Reviews
There are no reviews yet.